Incidence of Topical Tacrolimus Adverse Effects in Chronic Skin Disease

참고문헌 (9)

1. Luger T, "Potential new indications of topical calcineurin inhibitors", Dermatology, (215 Suppl 1), pp.45~54 (2007)
2. Rustin MH, "The safety of tacrolimus ointment for the treatment of atopic dermatitis : a review", Br J Dermatol, 157, pp.861~873 (2007)
3. Ständer S, "Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin", Br J Dermatol, 156, pp.1020~1026 (2007)
4. Powell FC, "Substance P and rosacea", J Am Acad Dermatol, 28, pp.132~133 (1993)
5. Lim YY, "A comparison of neuropeptide expression in skin with allergic contact dermatitis in human and mouse", Int J Dermatol, 51, pp.939~946 (2012)
6. Teresiak-Mikołajczak E, "Neurogenic markers of the inflammatory process in atopic dermatitis : relation to the severity and pruritus", Postepy Dermatol Alergol, 30, pp.286~292 (2013)
7. Al'Abadie MS, "Neuropeptide and neuronal marker studies in vitiligo", Br J Dermatol, 131, pp.160~165 (1994)
8. Falabella R, "Substance P may play a part during depigmentation in vitiligo. A pilot study", J Eur Acad Dermatol Venereol, 17, pp.355~356 (2003)
9. Hristakieva E, "Markers for vitiligo related neuropeptides in human skin nerve fibers", Acta Med Croatica, 54, pp.53~57 (2000)

관련 논문AI추천